ImmunityBio IBRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.98 | 185.33 | -0.06 | -64,683 | -62 | |
| 2025Q3 | 2.46 | 140.04 | -0.06 | -55,630 | -67 | |
| 2025Q2 | 2.64 | 112.40 | -0.11 | -71,285 | -93 | |
| 2025Q1 | 3.01 | 63.77 | -0.15 | -64,429 | -130 | |
| 2024Q4 | 2.56 | 234.62 | -0.09 | -69,400 | -59 | |
| 2024Q3 | 3.72 | 198.08 | -0.13 | -80,253 | -86 | |
| 2024Q2 | 6.32 | 98.78 | -0.20 | -99,333 | -135 | |
| 2024Q1 | 5.37 | 98.50 | -0.20 | -95,196 | -134 | |
| 2023Q4 | 5.02 | 42.18 | -0.38 | -85,389 | -233 | |
| 2023Q3 | 1.69 | 136.39 | -0.18 | -80,136 | -97 | |
| 2023Q2 | 2.78 | 82.96 | -0.32 | -85,145 | -142 | |
| 2023Q1 | 1.82 | 132.16 | -0.27 | -111,580 | -119 | |
| 2022Q4 | 5.07 | 116.16 | -0.27 | -84,900 | -112 | |
| 2022Q3 | 4.97 | 100.01 | -0.27 | -90,804 | -115 | |
| 2022Q2 | 3.72 | 98.17 | -0.24 | -79,622 | -98 | |
| 2022Q1 | 5.61 | 101.76 | -0.26 | -95,972 | -103 | |
| 2021Q4 | 6.08 | 99.93 | -0.23 | -79,274 | -92 | |
| 2021Q3 | 9.74 | 99.95 | -0.22 | -78,836 | -88 | |
| 2021Q2 | 14.28 | 90.84 | -0.23 | -85,906 | -88 | |
| 2021Q1 | 23.74 | 111.59 | -0.21 | -86,264 | -80 |